Related Experiment Video
Updated: Jun 21, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Atherosclerosis in survivors of Kawasaki disease
Monesha Gupta-Malhotra1, Dorota Gruber, Seena S Abraham
1Division of Pediatric Cardiology, Department of Pediatrics, Komansky Center for Children's Health, New York-Presbyterian Hospital, Weill-Cornell Medical College, New York, NY, USA. monesha.gupta@uth.tmc.edu
Objectives:
To test the hypothesis that long-term survivors of low-risk Kawasaki disease (KD) have ongoing vascular inflammation and dysfunction and a higher risk of accelerated atherosclerosis than healthy control subjects.
Study Design:
Twenty-eight patients with KD (7-20 years after acute illness) and 27 age-matched healthy control subjects were examined for medical and dietary history, serum markers of atherosclerotic risk and inflammation, carotid intimal-medial thickness (CIMT) with vascular ultrasound scanning and arterial stiffness with applanation tonometry.
Results:
Patients and control subjects were similar in age, sex, body mass index, waist-to-hip ratio, blood pressure, cigarette smoking, family history, diet, high-density lipoprotein cholesterol level, lipoprotein (a) level, homocysteine level, glucose level, insulin level, CIMT, arterial stiffness, C-reactive protein level, and inflammatory cytokine level. Levels of total cholesterol and apolipoprotein B were significantly higher in patients with KD than in control subjects.
Conclusions:
There was no evidence of increased atherosclerosis. Small but significant differences in cholesterol and apolipoprotein B levels could suggest increased future risk for atherosclerosis and warrant further study.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology